Castillo JJ - Search Results

1

PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies.

Winer ES, Ingham RR, Castillo JJ. Winer ES, et al. Among authors: castillo jj. Expert Opin Investig Drugs. 2012 Mar;21(3):355-61. doi: 10.1517/13543784.2012.656199. Epub 2012 Feb 3. Expert Opin Investig Drugs. 2012. PMID: 22300471 Review.

2

HIV-negative plasmablastic lymphoma: not in the mouth.

Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin GA, Butera JN. Castillo JJ, et al. Clin Lymphoma Myeloma Leuk. 2011 Apr;11(2):185-9. doi: 10.1016/j.clml.2011.03.008. Epub 2011 Apr 8. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21575922 Review.

3

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.

Reagan JL, Castillo JJ. Reagan JL, et al. Among authors: castillo jj. Expert Rev Anticancer Ther. 2011 Feb;11(2):151-60. doi: 10.1586/era.10.223. Expert Rev Anticancer Ther. 2011. PMID: 21342032 Review.

4

Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study.

Reagan JL, Sullivan MR, Winer ES, Lansigan F, Cardin MS, Castillo JJ. Reagan JL, et al. Among authors: castillo jj. Leuk Res. 2015 Aug;39(8):812-7. doi: 10.1016/j.leukres.2015.04.015. Epub 2015 May 2. Leuk Res. 2015. PMID: 26045177

5

The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies.

Fircanis S, Merriam P, Khan N, Castillo JJ. Fircanis S, et al. Among authors: castillo jj. Am J Hematol. 2014 Aug;89(8):E125-32. doi: 10.1002/ajh.23744. Epub 2014 May 8. Am J Hematol. 2014. PMID: 24753145

6

Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified.

Castillo JJ, Morales D, Quinones P, Cotrina E, Desposorio C, Beltran B. Castillo JJ, et al. Leuk Lymphoma. 2010 Oct;51(10):1822-8. doi: 10.3109/10428194.2010.508189. Leuk Lymphoma. 2010. PMID: 20849388

7

Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.

Nakhla PS, Butera JN, Treaba DO, Castillo JJ, Quesenberry PJ. Nakhla PS, et al. Among authors: castillo jj. Leuk Lymphoma. 2013 Aug;54(8):1647-51. doi: 10.3109/10428194.2012.753449. Epub 2013 Jan 2. Leuk Lymphoma. 2013. PMID: 23185961 Review.

8

Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.

Apor E, O'Brien J, Stephen M, Castillo JJ. Apor E, et al. Among authors: castillo jj. Leuk Res. 2014 Sep;38(9):1067-71. doi: 10.1016/j.leukres.2014.06.025. Epub 2014 Jul 10. Leuk Res. 2014. PMID: 25052307

9

Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia.

Reagan JL, Castillo JJ. Reagan JL, et al. Among authors: castillo jj. Future Oncol. 2014 May;10(7):1147-55. doi: 10.2217/fon.14.73. Future Oncol. 2014. PMID: 24947256 Review.

10

Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always.

Gavini A, Reagan JL, Winer ES, Castillo JJ. Gavini A, et al. Among authors: castillo jj. Am J Hematol. 2014 Aug;89(8):853-7. doi: 10.1002/ajh.23660. Epub 2014 Apr 10. Am J Hematol. 2014. PMID: 24382755 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results